Biological Safety Testing Market Current and Future Industry Trends, 2019 - 2026

The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period. The market is primarily driven by increasing production of new generation biologics by major pharmaceutical and biotechnology companies.

Biologics are products made from living organisms and has a unique set of properties. Safety of biologics is of utmost importance and specialized evaluation of the same is necessary. Biological safety testing is important for launching new products. Biological safety testing is done in order to ensure the safety quality and non-contamination of vaccines and biopharmaceuticals and to comply with the regulations for the same. Some of the major biological tests are sterility testing, residual host contaminant detection tests, bioburden testing and endotoxin tests.

Request Exclusive Free PDF Sample Of This Report @ https://dataintelo.com/request-sample/?reportId=622

Biological safety testing is used in cellular, vaccine and gene therapy products, tissue and tissue products, blood and blood products and others. Better living standards, increased funding for life science research and rising number of pharmaceutical and biological firms are major factors which have been driving the biological safety testing market globally.

Biological Safety Testing Market is anticipated to undergo transformations over the forecast period owing to the shift of trend in production economics.

Read More @ https://www.marketwatch.com/press-release/biological-safety-testing-market-current-and-future-industry-trends-2019---2026-2019-12-23